title: National Cancer Institute Formulary: A Public-Private Partnership Providing Investigators Access to Investigational Anticancer Agents.
abstract: As part of the White House Cancer Moonshot Initiative, the National Cancer Institute (NCI) has developed a drug formulary to provide investigational anticancer agents to the extramural research community. This article describes how the NCI Formulary functions, how researchers may apply for access to drugs in the formulary, and the NCI's initial goals for formulary participation. Approved investigators may apply for access to formulary agents at: https://nciformulary.cancer.gov.
authors.affiliation: Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, Maryland, USA.
authors.forename: J V
authors.initials: JV
authors.lastname: Cristofaro
authors.affiliation: Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, Maryland, USA.
authors.forename: S S
authors.initials: SS
authors.lastname: Ansher
authors.affiliation: Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, Maryland, USA.
authors.forename: J A
authors.initials: JA
authors.lastname: Zwiebel
authors.affiliation: Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, Maryland, USA.
authors.forename: P
authors.initials: P
authors.lastname: Ivy
authors.affiliation: Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, Maryland, USA.
authors.forename: B
authors.initials: B
authors.lastname: Conley
authors.affiliation: Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, Maryland, USA.
authors.forename: J S
authors.initials: JS
authors.lastname: Abrams
authors.affiliation: Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, Maryland, USA.|Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA.
authors.forename: J H
authors.initials: JH
authors.lastname: Doroshow
mesh_terms: D000970:Antineoplastic Agents; D015507:Drugs, Investigational; D005569:Formularies as Topic; D006801:Humans; D054547:National Cancer Institute (U.S.); D009369:Neoplasms / Q000188:drug therapy; D055818:Public-Private Sector Partnerships; D014481:United States
chemical_list: D000970:Antineoplastic Agents; D015507:Drugs, Investigational